Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Cytotherapy. 2016 Apr;18(4):536–545. doi: 10.1016/j.jcyt.2016.01.010

Figure 4. Total lung capacity (TLC) in mL at days 0, 7, and 14.

Figure 4

Group 1- Sal/Vehicle (representative normal healthy animals with no bleomycin exposure), Group 2- Blm/Vehicle, Group 3- Blm/low dose MSC, Group 4- Blm/high dose MSC. Data presented at Baseline or day 0 (A), day 7 (B), and day 14 (C).